articleTop 1% cited
Early discontinuation and non-adherence to adjuvant hormonal therapy are associated with increased mortality in women with breast cancer
Breast Cancer Research and Treatment · 2010 · Vol. 126(2) · pp. 529–537
Dawn L. Hershman✉(Columbia University Irving Medical Center)Theresa Shao(Royal College of Physicians)Lawrence H. Kushi(Kaiser Permanente)Donna Buono(Columbia University)Wei Yann Tsai(Columbia University)Louis Fehrenbacher(Kaiser Permanente)Marilyn L. Kwan(Kaiser Permanente)Scarlett Lin Gomez(Cancer Prevention Institute of California)Alfred I. Neugut(Columbia University)
Medication Adherence and CompliancePregnancy and Medication ImpactStatistical Methods in Clinical TrialsDiscontinuationMedicineMedical prescriptionBreast cancerProportional hazards modelInternal medicineHormone therapyHormonal therapyGynecologyCancer
MeSH terms
AgedBreast NeoplasmsFemaleHumansLymphatic MetastasisMiddle AgedPatient ComplianceTamoxifenProportional Hazards ModelsChemotherapy, AdjuvantAntineoplastic Agents, HormonalAromatase InhibitorsTumor BurdenKaplan-Meier Estimate
Funding
- U.S. Department of Defense
- American Cancer Society
- National Cancer Institute
Citations
872
FWCI
23.48
field-weighted impact
References
42
Percentile
100%
vs. same field & year
Citations per year
Cited by
Adherence to adjuvant hormonal therapy among breast cancer survivors in clinical practice: a systematic review
Breast Cancer Research and Treatment · 2012 · 712 citations
References
Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trials
The Lancet · 2005 · 7,586 citations
Adherence to tamoxifen over the five-year course
Breast Cancer Research and Treatment · 2006 · 319 citations
Adherence to Medication
New England Journal of Medicine · 2005 · 7,886 citations
Citation Network
How this paper connects to the literature. Drag to explore, click any node to open that paper.